WealthTrust Asset Management’s AbbVie ABBV Stock Holding History

WealthTrust Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	5,289 +423	+9%	+$91K	0.72%	28
2026 Q1	$1.06M	Buy	4,866 +956	+24%	+$212K	0.63%	32
2025 Q4	$893K	Buy	3,910 +9	+0.2%	+$2.05K	0.62%	39
2025 Q3	$903K	Buy	3,901 +11	+0.3%	+$2.24K	0.63%	37
2025 Q2	$722K	Sell	3,890 -554	-12%	-$103K	0.54%	46
2025 Q1	$931K	Sell	4,444 -285	-6%	-$55.4K	0.69%	31
2024 Q4	$840K	Sell	4,729 -83	-2%	-$15.3K	0.6%	41
2024 Q3	$950K	Buy	4,812 +15	+0.3%	+$2.8K	0.71%	35
2024 Q2	$823K	Buy	4,797 +17	+0.4%	+$2.82K	0.6%	43
2024 Q1	$870K	Sell	4,780 -43	-0.9%	-$7.41K	0.66%	35
2023 Q4	$747K	Buy	4,823 +38	+0.8%	+$5.54K	0.63%	42
2023 Q3	$713K	Sell	4,785 -518	-10%	-$76K	0.66%	41
2023 Q2	$714K	Buy	5,303 +121	+2%	+$17.7K	0.65%	41
2023 Q1	$826K	Buy	5,182 +17	+0.3%	+$2.6K	0.79%	40
2022 Q4	$835K	Sell	5,165 -379	-7%	-$58.1K	0.81%	33
2022 Q3	$744K	Buy	5,544 +113	+2%	+$16.2K	0.78%	36
2022 Q2	$832K	Sell	5,431 -37	-0.7%	-$5.65K	0.79%	37
2022 Q1	$886K	Sell	5,468 -230	-4%	-$33.4K	0.63%	39
2021 Q4	$772K	Sell	5,698 -87	-2%	-$10.3K	0.51%	39
2021 Q3	$624K	Sell	5,785 -20,585	-78%	-$2.35M	0.56%	37
2021 Q2	$2.97M	Buy	+26,370	New	+$2.97M	2.58%	12

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthTrust Asset Management's ABBV Position: Q2 2026 in Review

WealthTrust Asset Management increased its AbbVie (ABBV) stake by 8.7% in Q2 2026, buying an estimated $91K and bringing the position to 5,289 shares worth $1.33M. The position accounts for 0.72% of the portfolio, ranked #28.

WealthTrust Asset Management first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.97M in Q2 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

WealthTrust Asset Management held 5,289 shares of AbbVie worth $1.33M as of Q2 2026.
WealthTrust Asset Management bought 423 AbbVie shares in Q2 2026, an estimated $91K.
AbbVie made up 0.72% of WealthTrust Asset Management's portfolio in Q2 2026, its #28 holding.
WealthTrust Asset Management first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
WealthTrust Asset Management's AbbVie position peaked at $2.97M in Q2 2021.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WealthTrust Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.